WhiteHat Jr. founder Karan Bajaj has launched a new venture, Complement1, a health tech startup focused on personalized cancer care, and has secured $16 million in seed funding to support its growth.
🧬 Complement1: Personalized Cancer Care Through Lifestyle Coaching
Complement1 aims to revolutionize cancer care by integrating lifestyle modifications into treatment plans. The platform offers daily, one-on-one coaching—termed “CoActive Coaching”—that provides personalized guidance on physical activity, nutrition, and mind-body practices. This approach is tailored to each patient’s cancer type, treatment stage, and individual needs, with the goal of improving health outcomes and quality of life.
Clinical studies have shown that such lifestyle interventions can significantly reduce cancer recurrence and mortality rates. Complement1’s program has demonstrated over 90% adherence among users, leading to 37% fewer treatment side effects, 18% less pain, and 27% better sleep.
💰 Seed Funding to Scale Operations
The $16 million seed funding round was led by Owl Ventures and Blume Ventures, with participation from other healthcare-focused investors. The capital will be used to:
- Expand coaching infrastructure and operations across the United States
- Enhance the AI-driven personalization engine
- Develop partnerships with cancer centers, health plans, and employers
- Improve the digital user experience for patients and coaches
The funding reflects strong investor confidence in Complement1’s potential to transform cancer care through scalable, personalized interventions. Entrackr
👥 Leadership and Vision
Karan Bajaj, who previously sold WhiteHat Jr. to BYJU’S for $300 million, co-founded Complement1 with Trupti Mukker. Drawing from their experience in scaling tech-enabled services, they aim to address the often-overlooked aspect of lifestyle in cancer treatment. Their vision is to make personalized lifestyle coaching an integral part of oncology care, thereby improving patient outcomes and reducing healthcare costs.